| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 514738000 | Polyhydroxy | 44 |
| 20080207771 | Topical Compositions - The present invention provides new topical pharmaceutical or cosmetic compositions for the prevention and treatment of irritation of mucous cells, or skin cells, comprising a combination of: xylitol, myoinositol or mannitol or any combination of these; glycerol and/or urea; water; in the absence of any oil in water or wax in water emulsion. | 08-28-2008 |
| 20080214679 | TREATED BIODIESEL GLYCERIN - Disclosed are compositions that include treated biodiesel glycerin. The disclosed compositions may be utilized as soil-amendments for controlling pests, weeds and for enhancing growth of plants. The biodiesel glycerin utilized in the disclosed compositions may be treated by one or more steps including neutralization, heating, refluxing, condensing, and distilling. | 09-04-2008 |
| 20080275136 | Use of Glycerol for Improving Cardiac Function - The present invention relates to the use of glycerol for the regulation of cardiac metabolism, and notably for reducing myocardial β-oxidation of fatty acids for cardiac cytoprotection. | 11-06-2008 |
| 20090149552 | Pesticides based on vicinal diols - Pesticides based on vicinal diols, are available to control arthropod ectoparasites such as | 06-11-2009 |
| 20090170957 | SCYLLO-INOSITOL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES CHARACTERIZED BY ABNORMAL PROTEIN FOLDING OR AGGREGATION OR AMYLOID FORMATION, DEPOSITION, ACCUMULATION OR PERSISTENCE - Scyllo-Inositol derivatives represented by structural formula II are described, wherein at least one and not more than five of R | 07-02-2009 |
| 20090192231 | Antimicrobial Compositions And Methods Of Use Thereof - The invention provides antimicrobial compositions comprising one or more acid and one or more organic diol. In one embodiment, the invention's compositions have an acidic pH. The compositions may optionally further contain one or more oxidizing agent (including stabilized oxidizing agent and/or unstabilized oxidizing agent), and/or one or more surfactant. In particular embodiments, the acid lacks one or both of —NH group and —NH | 07-30-2009 |
| 20090221716 | Composition Comprising At Least 3 Different Diols - The present invention relates to a composition comprising at least 3 different diols, wherein said diols have the general structure (CH | 09-03-2009 |
| 20090247647 | Method of Stimulating Proteoglycan Synthesis in Cells - A method of stimulating the production of proteoglycans in a living animal cell comprising administering one or more Vitamin D | 10-01-2009 |
| 20100113613 | CYCLOHEXANE POLYALCOHOL FORMULATION FOR TREATMENT OF DISORDERS OF PROTEIN AGGREGATION - The invention provides formulations, dosage forms, and treatments comprising cyclohexane polyalcohol compounds that provide beneficial pharmacokinetic profiles in the treatment of a disorder and/or disease including a disorder in protein folding and/or aggregation, and/or amyloid formation, deposition, accumulation, or persistence. In aspects of the invention, a dosage form is provided comprising an amount of a cyclohexane polyalcohol compound suitable for administration to a subject to provide a therapeutically effective concentration of the compound in plasma, brain and/or cerebral spinal fluid and a pharmaceutically acceptable carrier, diluent or excipient. The formulation can be administered in a dose of 500, 1000, 2000, 3500, 5000 or 7000 mg of cyclohexane polyalcohol compound to achieve a mean plasma concentration profile having a mean AUC | 05-06-2010 |
| 20100144892 | METHOD OF PRODUCING ORGANIC CERTIFIED GLYCERIN - A process for the production of naturally and organically fermented glycerin includes cleaning and sanitizing of the fermentation equipment prior to fermentation without using any traditional synthetic organic hydrocarbon-based chemicals. The fermentation process uses a non-chemical nutrient and nitrogen source from natural proteins during the fermentation to reduce trace amounts of toxins or contaminants. A purification stage following the fermentation process increases the purity of the glycerin to a desired level. | 06-10-2010 |
| 20100160457 | Thickened Spreadable Warming Lubricant - A substantially anhydrous, thickened, spreadable, warming lubricant composition comprising a mixture of glycerin, polyhydric alcohol, a non-ionic surfactant, and a Carbomer thickener, the surfactant improving wetting and spreadability of the composition on skin and latex, and the thickener providing a creamy rich feel to the composition, such that the composition can be applied to skin or a condom and provide an optimal warming effect upon contact with ambient moisture during use and such that the composition can be added to a condom package and, over the course of a week, spread and coat nearly the entire internal and external surfaces of the condom. | 06-24-2010 |
| 20100168250 | USE OF CYCLOHEXANEHEXOL DERIVATIVES IN THE TREATMENT OF OCULAR DISEASE - The present invention relates to methods of treating ocular diseases in a subject by administering to the subject a therapeutically effective amount of one or more cyclohexanehexol derivatives, or salts thereof, or a medicament comprising a cyclohexanehexol derivative and a pharmaceutically acceptable carrier. More specifically, the invention provides a medicament comprising at least one cyclohexanehexol derivative of formula (III) or (IV) useful in preventing or treating ocular diseases, by modulating the folding, oligomerization or aggregation of amyloid β in ocular cells. Methods of administration of these medicaments include systemic, transpleural, oral, intravenously, intraarterial, intramuscular, topical, via inhalation, transdermal, subcutaneous, intraperitoneal, gastrointestinal, and directly to the eye or tissues surrounding the eyes. | 07-01-2010 |
| 20100190866 | ADVANCED ANTIMICROBIAL CARBON BLACK DISPERSION - Disclosed is an antimicrobial carbon black dispersion which exhibits excellent dispersant properties and also inhibits microbial contamination when used in consumer products such as cosmetic formulations. Also disclosed are methods for producing and using the antimicrobial carbon black dispersion. | 07-29-2010 |
| 20100216892 | Use of synergistically active 1,2-alkanediol mixtures as skin moisture-regulating compositions - Synergistically active mixtures of straight-chain 1,2-alkanediols having 5 to 10 C atoms and their use as skin moisture-regulating compositions are described. Binary and ternary mixtures of 1,2-pentanediol, 1,2-hexanediol and 1,2-octanediol have proved to be particularly active here. Cosmetic or pharmaceutical formulations and ready-to-use cosmetic or pharmaceutical products comprising particularly synergistically active mixtures of the 1,2-alkanediols mentioned and the use of these formulations and products are furthermore described. | 08-26-2010 |
| 20100305215 | DERMAL REGENERATION ENHANCER - An object of the present invention is to provide a novel dermal regeneration enhancer. In accordance with the present invention, there is provided a dermal regeneration enhancer as a novel pharmaceutical use of lyotropic liquid crystal which has been utilized as a basic material for pharmaceutical preparations for external application and for cosmetics, and the dermal regeneration enhancer of the present invention achieves an excellent suppressive effect to aging of the skin, generation of spots, etc. | 12-02-2010 |
| 20100324152 | USE OF 1,2-DECANEDIOL FOR SEBUM REDUCTION AND COSMETIC AND/OR DERMATOLOGICAL FORMULATIONS COMPRISING 1,2-DECANEDIOL - The present invention relates to a use of 1,2-decanediol for reduction of the sebum concentration of the skin, a cosmetic and/or dermatological formulation for topical application comprising 1,2-decanediol, a method for reduction of the sebum concentration of the skin and a use of 1,2-decanediol and a method for assisting the penetration of one, two, three, four or more active compounds into areas of the skin with increased sebum production. | 12-23-2010 |
| 20110021641 | SUSPENSION FORMULATION FOR CARBON ADSORBENTS - The invention relates to an aqueous suspension formulation comprising a coarsely particulate carbon adsorbent which is suitable for binding and eliminating harmful substances from the gastrointestinal tract, and a water-soluble or water-dispersible structure-forming agent and a humectant. | 01-27-2011 |
| 20110065806 | EMOLLIENT COMPOSITION FOR THE PREVENTIVE TREATMENT OF ATOPIC DERMATITIS - The invention relates to a composition for topical use that comprises a combination of glycerol, Vaseline and liquid paraffin as an active principle, in the form of an oil-in-water or water-in-oil emulsion, said composition being used in the prevention of atopic dermatitis. | 03-17-2011 |
| 20110071226 | EMOLLIENT COMPOSITION - The invention relates to an emollient composition for topical use that comprises a combination of glycerol, Vaseline and liquid paraffin as an active principle, in the form of an oil-in-water or water-in-oil emulsion. The invention also relates to: the use thereof for preparing a drug for treating dry skin conditions associated with certain dermatoses such as atopic dermatitis, ichthyosis conditions and psoriasis; the use thereof for preparing a drug for treating small superficial burns; and the use thereof for preparing a drug for preventing and/or treating and/or reducing the frequency and intensity of eczema attacks observed in patients suffering from atopic dermatitis. | 03-24-2011 |
| 20110144215 | BRUISE AMELIORATION COMPOSITION AND METHOD OF USE - A bruise amelioration composition that can be applied for one hour to an affected site, such as a bruise, contusion or blister, in the form of a gel, liquid or adhesive bandage. The composition includes at least 40% by weight of glycerin and at least 2% by weight of primrose oil. Preferably, the composition includes a fragrance, such as peach oil and marjoram and 1% to 10% by weight of vitamins A, C, D, E and K. | 06-16-2011 |
| 20120035273 | PHARMACEUTICAL COMPOSITION COMPRISING GLYCEROL, WHITE SOFT PARAFFIN AND LIQUID PARAFFIN FOR THE TREATMENT OF UREMIC XEROSIS AND/OR PRURITUS - The invention relates to a pharmaceutical composition comprising a combination of glycerol, white soft paraffin and liquid paraffin as active ingredients for topical use to treat uremic xerosis and/or uremic pruritus. | 02-09-2012 |
| 20120108674 | INJECTABLE HYDROGEL FOR THE LONG-TERM SUPPLEMENTATION OF GLYCEROL IN THE SKIN - An injectable hydrogel, includes, in weight, in a physiologically acceptable carrier fluid: 0.01 to 5% of glycerol and 0.1 to 5% of cross-linked hyaluronic acid, or one of the salts thereof; characterized in that the hyaluronic acid or one of the salts thereof is cross-linked by the formation of covalent bonds using bifunctional or polyfunctional molecules, the injectable hydrogel being sterilized in moist heat and having viscoelastic properties such that Tanδ at a frequency of 1 Hz is less than or equal to 1.10. A method for producing the hydrogel, to a kit containing the hydrogel, as well as to the use thereof in dermatology are also described. | 05-03-2012 |
| 20120129950 | ANTIMICROBIAL COMPOSITIONS - A method for rapid surface sanitization is provided, where the method includes contacting the surface with an effective amount of an antimicrobial composition comprising at least about 50 wt. % of a C | 05-24-2012 |
| 20130165530 | FOAMABLE ALCOHOLIC COMPOSITIONS WITH SKIN BENEFITS - A non-aqueous, non-aerosol foamable composition is provided that includes at least 40 wt % alcohol, based upon the total weight of the alcoholic composition; a foaming surfactant; and a skin benefit agent selected from the group consisting of emollients, humectants, occlusive agents, and other moisturizers to provide moisturization, skin softening, skin barrier maintenance, anti-irritation, or other skin health benefits. The foamable alcoholic composition forms a stable foam when mixed with air. | 06-27-2013 |
| 20130225693 | SKIN MOISTURIZER - Disclosed is a topical skin care composition and corresponding methods for its use comprising water, a cationic surfactant, an occlusive skin conditioning agent, a humectant skin conditioning agent, and a silicone containing compound. The composition is dermatologically acceptable and is capable of moisturizing skin for at least twelve hours after topical application to skin even after multiple washings of the skin. | 08-29-2013 |
| 20130261192 | MEDICAL ABSORBABLE HEMOSTATIC MATERIAL FOR BONE WOUNDS AND PREPARATION METHOD THEREFOR - A medical absorbable hemostatic and wound healing promoting material for bone wounds and a preparation method thereof. The absorbable hemostatic material for bone wounds is formed of 40-95% of a base material and 5-60% of an adjuvant, based on weight percent, wherein the base material is an oligosaccharide, a polysaccharide, or a mixture of the oligosaccharide and the polysaccharide, and the adjuvant includes (1) one or more polyhydric alcohols, (2) one or more vegetable oils, and (3) one or more emulsifying agents. The method for preparing the absorbable hemostatic and wound healing promoting material for bone wounds comprises mixing a base material and an adjuvant at prescribed amounts by chemical blending or latex blending, cooling to form a solid lump, packaging, and sterilizing. | 10-03-2013 |
| 20130289131 | INJECTABLE PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF JOINTS - The present invention relates to an injectable pharmaceutical formulation for the alleviation or reduction of joint irritation or for the reduction of worsening of existing joint inflammation, formulated for intra-articular injection comprising an active polyol ingredient, which polyol active ingredient is xylitol. Use of the intra-articular injectable formulations for the treatment of joint diseases or conditions including arthritis is described. | 10-31-2013 |
| 20130324618 | METHOD AND COMPOSITION FOR ENHANCING MILK PRODUCTION - The present invention concerns a method of enhancing milk production by a ruminant that includes providing a feed that contains sorbitol and at least one additional feed component, and orally feeding the feed to the ruminant, the ruminant ingesting about 100 grams, or less, of sorbitol per day. | 12-05-2013 |
| 20130324619 | GLYCOLS AS PATHOGEN INACTIVATING AGENTS - The disclosure relates to uses, methods and compositions for the inactivation of pathogens in biological compositions, using a glycol as a pathogen inactivating agent. | 12-05-2013 |
| 20130345315 | WATER-RELEASING COSMETIC COMPOSITION - A water-releasing cosmetic composition in the form of an emulsion and process for preparing the cosmetic composition are provided. The cosmetic composition includes an aqueous phase and an oil phase. The aqueous phase includes a hydrating agent at a concentration, by weight, of about 1% to about 50% and a preservative system at a concentration, by weight, based upon weight of the composition. The oil phase includes dimethicone at concentration, by weight of about 1% to about 40%, and an emulsifying crosslinked siloxane elastomer at a concentration, by weight, of about 3% to about 20%, both based upon weight of the composition. The cosmetic composition converts from an emulsion to a plurality of droplets upon rubbing. The process for preparing the water-releasing cosmetic composition includes regular or cold-processing methods to form the emulsion. | 12-26-2013 |
| 20130345316 | WATER-RELEASING COSMETIC COMPOSITION - A water-releasing cosmetic composition in the form of an emulsion and process for preparing the cosmetic composition are provided. The cosmetic composition includes an aqueous phase and an oil phase. The aqueous phase includes a hydrating agent at a concentration, by weight, of about 1% to about 50% and a preservative system at a concentration of about 0.1 to 3%, by weight, based upon weight of the composition. The oil phase includes dimethicone at concentration, by weight of about 1% to about 40%, and an emulsifying crosslinked siloxane elastomer at a concentration, by weight, of about 3% to about 20%, both based upon weight of the composition. The cosmetic composition has a phase ratio of the aqueous phase to the oil phase of about 1.5 to about 12.0. The cosmetic composition converts from an emulsion to a plurality of droplets upon rubbing. | 12-26-2013 |
| 20140018438 | METHOD OF DESTROYING BACTERIAL BIOFILM USING STERILE INTRAVENOUS OR INTRACAVERNOUS GLYCERIN - Disclosed is a method of preventing or inhibiting biofilm formation by a population of bacteria comprising the administration of a sterile intravenous normal saline solution containing glycerin and amino acids. In some embodiments, the concentration of glycerin in the normal saline solution is approximately 3%. In some embodiments, the concentration of amino acids in the normal saline solution is approximately 3%. In some embodiments, the intravenous solution is administered for 48 hours at 80 cc/hour. In some embodiments, the solution is infused via intracavernous administration into an infected body cavity. | 01-16-2014 |
| 20140051769 | METHOD AND COMPOSITION FOR IMPROVING THE HEALTH OF YOUNG MONOGASTRIC MAMMALS - A method of improving the health of a first group of young monogastric mammals, the first group of young monogastric mammals nursing from a first lactating monogastric mammal during a pre-weaning period, the method including feeding the first lactating monogastric mammal an effective amount of an animal feed during the pre-weaning period, and feeding the first lactating monogastric mammal an effective amount of sugar alcohol during the pre-weaning period. | 02-20-2014 |
| 20140107225 | THERAPEUTIC APPLICATION OF CEMBRANOIDS AGAINST HIV VIRUS REPLICATION, HIV-ASSOCIATED NEUROCOGNITIVE DISORDERS AND HIV VIRUS-INDUCED INFLAMMATION. - A method and composition for suppressing replication of the HIV-1 virus strains, modulating the production and liberation of inflammatory mediators; and the prevention and treatment of neurocognitive disorders. The method comprises administering to a subject an effective amount of an a macrocyclic diterpenoid, such as 4R cembranoid. | 04-17-2014 |
| 20140323588 | Topical Formulation for Pain Relief - Described herein are topical pain compositions comprising between 15 and 90% mannitol, for use in the treatment of pain, itch and other cutaneous nerve conditions. The resulting compositions may be in the form of creams, gels, lotions, ointments, foams, suppositories, and sprays. | 10-30-2014 |
| 20140357728 | PESTICIDES BASED ON VICINAL DIOLS - Pesticides based on hydroxy-substituted hydrocarbyl compounds, particularly vicinal diols, are available to control arthropod ectoparasites such as | 12-04-2014 |
| 20150011653 | Novel Microbial Pathogen inhibitor - A formulation containing xylitol is used in a variety of ways to inhibit the ability of microorganisms to adhere to mucus membranes in the lungs throat, bladder, colon, ears, skin and rectum, and subsequently infect the host. | 01-08-2015 |
| 20150011654 | STABLE WATER-IN-OIL EMULSIONS WITH HLB-TYPE EMULSIFIERS - Cosmetic and/or dermatological preparations based on a water-in-oil emulsion comprising at least two W/O emulsifiers which differ in their HLB value up to a maximum of 1 lead to sensorily acceptable preparations and at the same stable W/O emulsions. | 01-08-2015 |
| 20150038592 | STABLE WATER-IN-OIL EMULSIONS WITH SPREADABLE OILS - The invention comprises a cosmetic and/or dermatological preparation based on water-in-oil emulsions, comprising at least two W/O emulsifiers and at least one oil having a spreadability value of more than 600 mm | 02-05-2015 |
| 20150296839 | METHODS FOR FEEDING SOWS AND FOR IMPROVING THE HEALTH OF YOUNG PIGLETS - A method of improving the health of a first group of young monogastric mammals, the first group of young monogastric mammals nursing from a first lactating monogastric mammal during a pre-weaning period, the method including feeding the first lactating monogastric mammal an effective amount of an animal feed during the pre-weaning period, and feeding the first lactating monogastric mammal an effective amount of sugar alcohol during the pre-weaning period. | 10-22-2015 |
| 20160000730 | MANAGING OSTEOPOROSIS WITH HMW PEG - The present invention relates to the administration of compositions comprising polyethylene glycol, for improving the general gastrointestinal health of an animal increasing growth performance and treating osteopenia, osteoporosis and other bone disorders. | 01-07-2016 |
| 20160045414 | 1,2-ALKANE POLYOL-CONTAINING COMPOSITION - Provided is a composition containing, as an alkane polyol, a C | 02-18-2016 |
| 20160193158 | METHOD AND COMPOSITION FOR ENHANCING MILK PRODUCTION | 07-07-2016 |
| 20170231921 | METHOD AND COMPOSITION FOR ENHANCING MILK PRODUCTION | 08-17-2017 |
